Molecular Biology and Pathology of Paediatric Cancer

Edited by Catherine J. Cullinane, Susan A. Burchill, Jeremy A. Squire, John J. O'Leary, and Ian J. Lewis

360 pages | 8 pp colour plates; numerous black & white photographs, line illustrations and tables | 246x189mm

978-0-19-263079-7 | Hardback | 13 November 2003

Price: £185.00

This item is printed to order and supplied on a firm sale basis. Items which are printed to order are normally despatched and charged within 5-10 days.

Add to Wish List

The editorial team combines both scientific and clinical expertise and an international list of contributors
The molecular study of paediatric tumours have contributed enormously to our understanding of the pathogenesis of paediatric oncology

There has been an explosion of knowledge and enormous progress in the fundamental understanding of the biology of cancer in recent years. This has included the realisation that cancer occurs when normal cellular functions are disturbed leading to a malignant phenotype. Much research has focussed on understanding the types of disturbances that can occur, the contribution that these abnormalities can make to the development and behaviour of particular cancers and more recently, the recognition that these cellular and genetic abnormalities can provide rational targets for new therapeutic approaches. Information about the biology of cancers that occur in children has increased in parallel with these more general advances and this book is intended to provide a focus for readers who wish to have an understanding of our current state of knowledge.

A international group of editors and contributors provide guidelines on the molecular biology and pathology of paediatric oncology, aimed at clinicians and scientists working in the specialty who wish to understand current developments in molecular pathology as applied to their field. The book is a broad ranging review focusing on the impact of molecular and cytogenetic techniques on our understanding of the aetiology, clinical behaviour, diagnosis and management of paediatric cancer. The first section outlines the laboratory handling of tissue samples, theory and methodology of cytogenetic and molecular techniques and discusses predisposition syndromes. The second section highlights the application of cytogenetic and molecular methods in diagnosis and treatment of the major paediatric cancers.

Readership: Clinicians in paediatric oncology and clinical oncologists who need to understand the means of diagnosis. The book will also be of value to scientists in the field and clinicians in other specialties such as haematology who deal with leukaemia and lymphoma. Aimed also at newly qualified medical staff, individuals working in paediatric pathology or research or service laboratories involved in diagnostic/prognostic work.

Edited by Catherine J. Cullinane, Department of Pathology, St James's University Hospital, Leeds, UK, Susan A. Burchill, Candlelighter's Children's Cancer Research Laboratory, Cancer Research UK Clinical Centre, St James's University Hospital, Leeds, UK, Jeremy A. Squire, Ontario Cancer Institute, Division of Cellular and Molecular Biology, University of Toronto, Canada, John J. O'Leary, Department of Pathology, Coombe Women's Hospital, St James's Hospital and Trinity College, Dublin, Ireland, and Ian J. Lewis, Yorkshire Regional Centre for Paediatric Oncology and Haematology, St James's University Hospital, Leeds, UK

Contributors:
Pedram Argani, Paediatric Pathologist, The National Wilms Tumor Study Group Pathology Center, Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, USA

Jane Bayani, University Health Network, Ontario Cancer Institute and the Departments of Laboratory Medicine and Pathobiology, and Medical Biophysics, University of Toronto, Canada

W. Bell, Division of Pathology, The University of Alabama at Birmingham, USA

Susan A. Burchill, Senior Scientist, Candlelighter's Children's Cancer Research Laboratory, ICRF Cancer Medicine Research Unit, St James's University Hospital, Leeds, UK

Catherine Cullinane, Paediatric Pathologist, Department of Pathology, St James's University Hospital, Leeds, UK

Milton J. Finegold, Professor of Pathology and Paediatrics, Department of Pathology, Texas Children's Hospital, Houston, USA

Mary V. Gresik, Associate Professor of Pathology, Baylor College of Medicine, Houston, USA

Elizabeth S. Gray, Paediatric Pathologist, Department of Pathology, University of Aberdeen, UK

Venita Jay, Associate Professor, Departments of Laboratory Medicine and Pathobiology and Ophthalmololgy, The University of Toronto, and Neuropathologist and ophthalmic pathologist, The Hospital for Sick Children and Women's College Hospital, Toronto, Ontario, Canada

Ivo Leuschner, Pathologist, Institut fur Paidpathologie, Universitatslinikum Kiel, Germany

Ian A. Lewis, Paediatric Oncologist, Department of Paediatric Oncology, Yorkshire Regional Paediatric Oncology Service, St James's University Hospital, Leeds, UK

Cara Martin, Pathology Department, Coombe Maternity Hospital, Dublin, Ireland

John J. O'Leary, Pathologist, Pathology Department, Coombe Maternity Hospital, Dublin, Ireland

David M. Parham, Pediatric Pathologist, Departments of Pathology, University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock, USA

Elizabeth J. Perlman, Pediatric Pathologist, The National Wilms Tumor Study Group Pathology Center, Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, USA

Orla Shiels, Pathology Department, Coombe Maternity Hospital, Dublin, Ireland

Eamonn G. Sheridan, Clinical Geneticist, Yorkshire Regional Genetics Service, St James's University Hospital, Leeds UK

Gene P. Siegal, Professor of Pathology, Cell Biology and Surgery, Division of Pathology, The University of Alabama at Birmingham, USA

J. A. Squire, Faculty of Medicine, University of Toronto, Toronto, Canada

J. Robert Thomas, Pathologist, Departments of Pathology, University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock, USA

Sadik Variend, Paediatric Pathologist, Department of Pathology, Sheffield Children's Hospital, Sheffield UK

Sheila Weitzman, Pediatric Oncologist, Department of Oncology, The Hospital for Sick Children, Toronto, Canada

C. Geoffrey Woods, Clinical Geneticist, Yorkshire Regional Genetics Service, St James's University Hospital, Leeds UK

Maria Zielenska, Assistant Professor, Department of Laboratory Medicine and Pathobiology, The University of Toronto and Molecular Diagnostics, Hospital for Sick Children, Toronto, Canada

Molecular Biology and Pathology of Paediatric Cancer

Share